RAB27A-mediated Melanoma Exosomes: Promoters of Invasion and Metastasis

Overview

Journal Transl Cancer Res

Specialty Oncology

Date 2022 Feb 4

PMID 35116811

Authors

Dajiang Guo

Shweta Tikoo

Nikolas K Haass

Affiliations

Soon will be listed here.

Citing Articles

Small Extracellular Vesicles and COVID19-Using the "Trojan Horse" to Tackle the Giant.

Borowiec B, Angelova Volponi A, Mozdziak P, Kempisty B, Dyszkiewicz-Konwinska M Cells. 2021; 10(12).

PMID: 34943891 PMC: 8699232. DOI: 10.3390/cells10123383.

Prognostic significance of Rab27 expression in solid cancer: a systematic review and meta-analysis.

Koh H, Jang B, Kim D Sci Rep. 2020; 10(1):14136.

PMID: 32839520 PMC: 7445175. DOI: 10.1038/s41598-020-71104-9.

References

Akavia U, Litvin O, Kim J, Sanchez-Garcia F, Kotliar D, Causton H . An integrated approach to uncover drivers of cancer. Cell. 2010; 143(6):1005-17. PMC: 3013278. DOI: 10.1016/j.cell.2010.11.013. View

Li J, Chen J, Wang S, Li P, Zheng C, Zhou X . Blockage of transferred exosome-shuttled miR-494 inhibits melanoma growth and metastasis. J Cell Physiol. 2019; 234(9):15763-15774. DOI: 10.1002/jcp.28234. View

Luke J, Flaherty K, Ribas A, Long G . Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol. 2017; 14(8):463-482. DOI: 10.1038/nrclinonc.2017.43. View

Chairoungdua A, Smith D, Pochard P, Hull M, Caplan M . Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling. J Cell Biol. 2010; 190(6):1079-91. PMC: 3101591. DOI: 10.1083/jcb.201002049. View

Guo D, Lui G, Lai S, Wilmott J, Tikoo S, Jackett L . RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes. Int J Cancer. 2018; 144(12):3070-3085. DOI: 10.1002/ijc.32064. View

Chen G, Huang A, Zhang W, Zhang G, Wu M, Xu W . Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018; 560(7718):382-386. PMC: 6095740. DOI: 10.1038/s41586-018-0392-8. View

Giles K, Brown R, Ganda C, Podgorny M, Candy P, Wintle L . microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB. Oncotarget. 2016; 7(22):31663-80. PMC: 5077967. DOI: 10.18632/oncotarget.9421. View

Zhou X, Yan T, Huang C, Xu Z, Wang L, Jiang E . Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway. J Exp Clin Cancer Res. 2018; 37(1):242. PMC: 6169013. DOI: 10.1186/s13046-018-0911-3. View

Lunavat T, Cheng L, Einarsdottir B, Olofsson Bagge R, Muralidharan S, Sharples R . BRAF inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells. Proc Natl Acad Sci U S A. 2017; 114(29):E5930-E5939. PMC: 5530690. DOI: 10.1073/pnas.1705206114. View

10.

Somasundaram R, Herlyn M . Melanoma exosomes: messengers of metastasis. Nat Med. 2012; 18(6):853-4. DOI: 10.1038/nm.2775. View

11.

Mathieu M, Martin-Jaular L, Lavieu G, Thery C . Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat Cell Biol. 2019; 21(1):9-17. DOI: 10.1038/s41556-018-0250-9. View

12.

Buschow S, Nolte-t Hoen E, van Niel G, Pols M, Ten Broeke T, Lauwen M . MHC II in dendritic cells is targeted to lysosomes or T cell-induced exosomes via distinct multivesicular body pathways. Traffic. 2009; 10(10):1528-42. DOI: 10.1111/j.1600-0854.2009.00963.x. View

13.

Felicetti F, De Feo A, Coscia C, Puglisi R, Pedini F, Pasquini L . Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma. J Transl Med. 2016; 14:56. PMC: 4765208. DOI: 10.1186/s12967-016-0811-2. View

14.

Ostrowski M, Carmo N, Krumeich S, Fanget I, Raposo G, Savina A . Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2009; 12(1):19-30. DOI: 10.1038/ncb2000. View

15.

Thery C, Zitvogel L, Amigorena S . Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002; 2(8):569-79. DOI: 10.1038/nri855. View

16.

Gajos-Michniewicz A, Czyz M . Role of miRNAs in Melanoma Metastasis. Cancers (Basel). 2019; 11(3). PMC: 6468614. DOI: 10.3390/cancers11030326. View

17.

Azmi A, Bao B, Sarkar F . Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013; 32(3-4):623-42. PMC: 3843988. DOI: 10.1007/s10555-013-9441-9. View

18.

Jeppesen D, Fenix A, Franklin J, Higginbotham J, Zhang Q, Zimmerman L . Reassessment of Exosome Composition. Cell. 2019; 177(2):428-445.e18. PMC: 6664447. DOI: 10.1016/j.cell.2019.02.029. View

19.

Zoller M . Exosomes in Cancer Disease. Methods Mol Biol. 2015; 1381:111-49. DOI: 10.1007/978-1-4939-3204-7_7. View

20.

Shu S, Yang Y, Allen C, Maguire O, Minderman H, Sen A . Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment. Sci Rep. 2018; 8(1):12905. PMC: 6110845. DOI: 10.1038/s41598-018-31323-7. View